BTW @djg3012 , @diverdown1 , @covidstinks2023 all- look at this: I just found this online TODAY!!
The Core Science: Mast Cells Express GLP-1 ReceptorsMechanism of Action: Peer-reviewed immunological data shows that human mast cells express GLP-1 receptors on their cellular surfaces.Stabilization Effect: When a GLP-1 receptor agonist (such as semaglutide) binds to these receptors, it acts as a direct mast cell stabilizer. It down-regulates the release of pro-inflammatory mediators, pro-inflammatory cytokines (like IL-6 and TNF-α), and systemic histamine.2. The Landmark July 2025 Case Series (Afrin, Weinstock, Dempsey)Study Citation: Afrin LB, Weinstock LB, Dempsey T, et al. "Utility of glucagon-like-peptide-1-receptor agonists in mast cell activation syndrome." The American Journal of the Medical Sciences.The Cohort: The study evaluated 47 patients with treatment-resistant, refractory MCAS who had failed conventional histamine-blockade therapy.The Efficacy Rate: An astounding 89% of MCAS patients demonstrated meaningful clinical benefit across a wide range of multisystem symptoms, including gastrointestinal inflammation, neurological flares, and profound fatigue.Clinical Observation: Many patients reported rapid, dramatic improvements in food tolerances and a reduction in localized GI pain within weeks of initiating therapy.